Bioprocessing Companies Push Limits of Upstream Technologies
Goal Is to Maximize Efficiency in Bioprocess Operations
Scaling Up Cell Therapy Manufacturing
Moving Forward with an Early-on Strategy
This is Your Brain on DREADDs
Chemogenetics Provides a Noninvasive Tool for Precise Control of Neural Circuits
10 Takeover Targets to Watch This Fall
Pace of Biopharma M&A Slows from First Half Stampede of Deals
For full access to this article login to GEN Select now.
Laskers Honor Stem Cell & Cancer Research
Basic and Medical Investigations Recognized Expected to Give the Biotech Industry a Boost
- The 2009 Lasker Awards, which were announced last month, have far-reaching implications for the biotechnology and pharmaceutical industries, as companies seek to expand their research and development to fulfill the promise of stem cells. Collaborations between academia and industry will accelerate, particularly in adult stem cell investigation. “The ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.